Feb 6, 2026
How have specific independent individual patient data re-analyses changed regulatory decisions in the last decade?
of individual participant (patient) data (IPD) have highlighted both the promise and the limits of re-checking trial results: they have forced regulatory attention on , reproducibility, and frameworks...